Seaport Therapeutics Inc banner

Intrinsic Value

Not Available for SPTX

There is not enough data to reliably calculate the intrinsic value for Seaport Therapeutics Inc.

Do our valuations actually work? See backtest results .

Alternatives to SPTX

Fundamental Analysis

What Seaport Therapeutics Does

Pharmaceuticals Health Care

Seaport Therapeutics, Inc. is a clinical-stage therapeutics company, which engages in the provision of inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company is headquartered in Boston, Massachusetts and currently employs 58 full-time employees. The company went IPO on 2026-05-01. The firm is focused on inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders.

Headquarters
United States of America US
Employees
58
IPO date
May 1, 2026
Read the full company overview
View Company Overview
Financials

Revenue & Expenses Breakdown
Seaport Therapeutics Inc

Efficiency

Earnings Waterfall
Seaport Therapeutics Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Ownership

SPTX Insider Trading
Buy and sell transactions by insiders